Group A (n = 23) | Group B (n = 15) | Group C (n = 26) | |
---|---|---|---|
Female, n | 16 | 12 | 19 |
Age (year) | 10.00 ± 2.04 | 10.47 ± 2.33 | 11.43 ± 2.50 |
Time from first symptoms to final diagnosis (day) | 9 (5, 14) â–³ | 15 (10, 20) | 15 (10, 60) â–³ |
Family history of SLE, n | 1 | 1 | 1 |
Hypertension, n | 14 | 6 | 15 |
Pulmonary involvement, n | 14 | 10 | 16 |
Cardiac involvement, n | 11 | 6 | 7 |
Ophthalmologic involvement, n | 3 | 2 | 1 |
Neurological involvement, n | 7 | 5 | 6 |
SLEDAI-2 K | 28.70 ± 7.17*△ | 21.07 ± 5.18* | 20.62 ± 5.67△ |
Rash, n | 18 | 8 | 15 |
Swelling, n | 13 | 8 | 12 |
Fever, n | 11 | 7 | 11 |